ic9 - med chem of drugs for coagulation disorders and inflammation Flashcards
(91 cards)
what are the classes of drugs that are used to tx coagulation disorders
VKA - warfarin, phenindione
direct thrombin inhibitor (under DOACs) - dabigatran
antifactor Xa inhibitor (under DOACs) - rivaroxaban, apixaban
antiplatelets - aspirin, clopidogrel, ticagrelor
what is warfarin a derivative of
coumarin
what is the structure of coumarin
fused bicyclic ring containing a lactone ring
(benzene with O hexacyclic with lactone)
substituents often at positions 3 and 4
what is the structure of warfarin
from coumarin structure then
OH substituted on position 3, CH(benzene)CH2C=O(CH3) on position 4
what is another derivative of coumarin apart from warfarin and what is its structure
from coumarin structure,
OH substituted on position 3
x2 the current structure
and connect the two with a methylene aka CH3
what is the pKa of warfarin and which is the ionisable group
warfarin is acidic as the OH substituted on position 3 (becomes an enol) and is ionisable (vs regular OH) and can form a Na salt
pKa is 5.1
O- conjugated with double bond thus can form resonance and is stable -> thus forming enolic anion
note that in order to form a Na salt, a base is required thus warfarin is acidic
what properties does warfarin have
warfarin has a chiral carbon thus it forms a racemic mixture (S-warfarin is active)
forms a hemiketal
highly protein bound
cross sensitivity with 1,3-indandiones
what is the r/s of the pKa values to acidity
lower pKa means more acidic (bc lower pKa means higher Ka)
strong acids usually pKa -ve
strong bases usaully pKa >14
what is the structure and properties of 1,3-indandione
indane structure (fused bicyclic hydrocarbon ring -> benzene fused with cyclopentane) with two ketone group on position 1 and 3
possessed renal and hepatic toxicities thus use is precluded
how to deduce which is S-enantiomer
rank the groups based on priority then direct the least priority group away from you
ranking for S-enantiomer should be ACW
how does warfarin form a hemiketal
OH on position 3 attack carbonyl C to form a six membered ring which is very stable (relate to stability of cyclohexane)
why is cyclohexane so stable
forms a chair conformation thus no angle strains
how are hemiketals formed
formation of hemiketals occur when an alcohol O atom adds to the carbonyl C of an aldehyde or a ketone through nucleophilic attack of the hydroxyl group at the electrophilic carbonyl group
what does it mean if a group or an atom is electrophilic
it is electron deficient (partial pos sign)
what is the structure and properties of phenindione
from indane structure (benzene fused with cyclopentane), add enol group at position 1 and a benzene at position 2 and a ketone group at position 3
acidic with pKa of 4
exhibits tautomerism
what is the structure and properties of phenindione (pKa)
from indane structure (benzene fused with cyclopentane), add enol group at position 1 and a benzene at position 2 and a ketone group at position 3
exhibits tautomerim
acidic with pKa of 4
what is tautomerism
converting between stable keto and stable enol
what is the moa of warfarin
vitK is a cofactor for glutamic acid residue on N terminal of II, VII, IX, X and protein C to form gamma glutamyl carboxylase (GGCX) enzyme which causes conformational changes to protein by chelation with Ca ions thus activating these vitK dependent clotting factor
these clotting factors and GGRX are important for post translational carboxylation of prothrombin
in this process, vitK hydroquinone is converted to vitK epoxide in presence of O2 and CO2 which then under goes redox cycling whereby the epoxide is reduced by vitK epoxide reductase (VKOR)C1 to vit K which is in turn converted back to vitK hydroquinone by vitK reductase (VKR)
warfarin is vitK antagonists that act on VKOR and VKR such that it leads to the eventual decr in recycling of vitK into vitK hydroquinone
draw the structures of vitK, vitK hydroquinone and vitK epoxide
vitK hydroquinone is reduced form while vitK epoxide is oxidised form
what is the moa of dabigatran
in coagulation cascade, thrombin (factor IIa) catalyses the conversion of fibrinogen to soluble fibrin which turns insoluble by factor XIIa
DTI binds directly and reversibly to the active site of thrombin and inactivate free and fibrin bound thrombin
what are other examples of direct thrombin inhibitors (DTI) (peptidic and nonpeptidomimetic)
peptidic DTI: desirudin, bivalirudin
nonpeptidomimetic: dabigatran etexilate (DE)
what is the structure of DE and properties of dabigatran (indication, activation, cLogP of D and DE, s/e)
indication: used for prevention of stroke and blood clots in AF
activation: DE is a prodrug and is activated by esterase -> ester and carbamate hydrolyses to form dabigatran
cLogP: 0.79 for D vs 3.8 for DE
s/e: significant incr in risk for GI bleed
what does LogP value indicate
lipophilicity, higher LogP/cLogP means higher lipophilicity
why does DE have higher cLogP than dabigatran
DE has nonpolar groups like methyl groups which incr lipophilicity